Literature DB >> 21981985

PADI4 polymorphisms and related haplotype in rheumatoid arthritis patients.

Somia H Abd-Allah1, Amal S el-Shal, Sally M Shalaby, Heba F Pasha, Amany M Abou el-Saoud, Amany R el-Najjar, Eman E el-Shahawy.   

Abstract

OBJECTIVE: To investigate whether peptidyl arginine deiminase type IV gene (PADI4) polymorphisms contribute to rheumatoid arthritis (RA) susceptibility in Egyptians, whether they influence disease severity and activity, and whether they affect anti-mutated citrullinated vimentin antibodies (anti-MCV) level.
METHODS: Three PADI4 single nucleotide polymorphisms (SNPs) (PADI4-92, PADI4-96, and PADI4-102) were screened in 275 RA patients and 275 unaffected controls by polymerase chain reaction-based restriction fragment length polymorphism (PCR-RFLP) method. Serum anti-MCV levels were measured by enzyme-linked immunosorbent assay (ELISA).
RESULTS: There were significant associations between RA susceptibility with the minor alleles of PADI4-92 and PADI4-102 [odds ratio (OD) and 95% confidence interval (CI) for the minor alleles of PADI4-92 and PADI4-102: 1.48 (1.17-1.88) and 2.05 (1.61-2.61) respectively] but not with PADI4-96 [OD and 95% CI for the C allele: 1.09 (0.86-1.39)]. PADI4 haplotypes 2 (GCC) and 3 (GCT) were also associated with RA susceptibility while PADI4 haplotypes 1 (CTC) may be protective against developing of this disease. A significant association was detected between PADI4 haplotypes and RA severity.
CONCLUSIONS: The PADI4 SNPs and haplotypes were associated with RA susceptibility, although no relation was observed between the PADI4 haplotypes and anti-MCV levels. Copyright Â
© 2011 Société française de rhumatologie. Published by Elsevier SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21981985     DOI: 10.1016/j.jbspin.2011.07.006

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


  6 in total

1.  Association between susceptibility to rheumatoid arthritis and PADI4 polymorphisms: a meta-analysis.

Authors:  Young Ho Lee; Sang-Cheol Bae
Journal:  Clin Rheumatol       Date:  2015-10-16       Impact factor: 2.980

Review 2.  Understanding the major risk factors in the beginning and the progression of rheumatoid arthritis: current scenario and future prospects.

Authors:  Mahendra Kumar Verma; Kota Sobha
Journal:  Inflamm Res       Date:  2015-07-07       Impact factor: 4.575

3.  PADI2 is significantly associated with rheumatoid arthritis.

Authors:  Xiaotian Chang; Yifang Xia; Jihong Pan; Qingsong Meng; Yan Zhao; Xinfeng Yan
Journal:  PLoS One       Date:  2013-12-05       Impact factor: 3.240

4.  Bioinformatic screening of autoimmune disease genes and protein structure prediction with FAMS for drug discovery.

Authors:  Shigeharu Ishida; Hideaki Umeyama; Mitsuo Iwadate; Y-H Taguchi
Journal:  Protein Pept Lett       Date:  2014       Impact factor: 1.890

5.  Investigation of Caucasian rheumatoid arthritis susceptibility loci in African patients with the same disease.

Authors:  Sebastien Viatte; Edward Flynn; Mark Lunt; Joanne Barnes; Madeleine Singwe-Ngandeu; Sylvette Bas; Anne Barton; Cem Gabay
Journal:  Arthritis Res Ther       Date:  2012-11-03       Impact factor: 5.156

6.  PADI4 rs2240337 G>A polymorphism is associated with susceptibility of esophageal squamous cell carcinoma in a Chinese population.

Authors:  Liming Wang; Haiyong Gu; Tao Long; Huiwen Pan; Lu Lv; Yijun Shi; Jingfeng Zhu; Yangyong Sun; Weifeng Tang; Guowen Ding; Suocheng Chen; Yu Fan; Hao Ding; Cheng Qian; Qun Wang; Jun Yao; Lijie Tan; Jun Yin
Journal:  Oncotarget       Date:  2017-09-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.